Xie Bowen, Semaan Dana B, Sridharan Natalie D, Eslami Mohammad H, Go Catherine
Division of Vascular Surgery, UPMC, Pittsburgh, PA.
Ann Vasc Surg Brief Rep Innov. 2023 Mar;3(1). doi: 10.1016/j.avsurg.2022.100153. Epub 2022 Dec 23.
Vaccine-associated thrombosis has previously been described in patients presenting with cerebral sinus thrombosis, deep venous thrombosis/pulmonary embolism, or mesenteric venous thrombosis. Only recently has arterial thrombosis gained attention. A new entity known as vaccine-induced thrombotic thrombocytopenia (VITT) has been associated with the coronavirus disease of 2019 (COVID-19) vaccines produced by AstraZeneca and Johnson & Johnson. We describe a case series of three patients who presented with acute limb ischemia with vaccine-associated arterial occlusions, one of whom was diagnosed with VITT.
疫苗相关血栓形成此前已在出现脑窦血栓形成、深静脉血栓形成/肺栓塞或肠系膜静脉血栓形成的患者中有所描述。直到最近,动脉血栓形成才受到关注。一种名为疫苗诱导的血栓性血小板减少症(VITT)的新病症已与阿斯利康和强生公司生产的2019冠状病毒病(COVID-19)疫苗相关联。我们描述了一组三例因疫苗相关动脉闭塞而出现急性肢体缺血的患者病例系列,其中一例被诊断为VITT。